Patrick O. Richard

Building resilience in oncology teams: Protocol for a realist evaluation of multiple cases

T. Poder, Kelley Kilpatrick, M. Généreux, 2022, PloS one.

Intravesical immunotherapy with a GM-CSF armed oncolytic vesicular stomatitis virus improves outcome in bladder cancer

L. Tai, M. Koti, Marie Boudaud, 2022, Molecular therapy oncolytics.

Theranostic 64Cu-DOTHA2-PSMA allows low toxicity radioligand therapy in mice prostate cancer model

B. Guérin, S. Geha, Véronique Dumulon-Perreault, 2023, Frontiers in Oncology.

Development and use of research vignettes to collect qualitative data from healthcare professionals: a scoping review

T. Poder, Kelley Kilpatrick, N. Touati, 2022, BMJ Open.

64Cu-DOTHA2-PSMA, a Novel PSMA PET Radiotracer for Prostate Cancer with a Long Imaging Time Window

B. Guérin, Véronique Dumulon-Perreault, S. Ait-Mohand, 2022, Pharmaceuticals.